共 34 条
[1]
Snyder, Clinical use of white cell poor components, Transfusion, 29, pp. 568-571, (1989)
[2]
Anderson, Weinstein, Graft versus host disease after transfusion, N Engl J Med, 323, pp. 315-321, (1990)
[3]
Blumberg, Heal, Transfusion and host defenses against cancer recurrence and infection, Transfusion, 29, pp. 236-245, (1989)
[4]
De Rie, van der Plas-van Dalen, Englefriet, von dem Borne, The serology of febrile transfusion reactions, Vox Sang, 49, pp. 126-134, (1985)
[5]
Heinrich, Mueller-Eckhardt, Stier, The specificity of leukocyte and platelet alloantibodies in sera of patients with nonhemolytic transfusion reactions. Absorption and elution studies, Vox Sang, 25, pp. 442-456, (1973)
[6]
Payne, The association of febrile transfusion reactions with leuko-agglutinins, Vox Sang, 2, pp. 233-241, (1957)
[7]
Brubaker, Clinical significance of white cell antibodies in febrile non-hemolytic transfusion reactions, Transfusion, 30, pp. 733-737, (1990)
[8]
Menitove, McElligott, Aster, Febrile transfusion reaction: what blood component should be given next?, Vox Sang, 42, pp. 318-321, (1982)
[9]
Chambers, Kruskall, Pacini, Donovan, Febrile reactions after platelet transfusion: the effect of single versus multiple donors, Transfusion, 30, pp. 219-221, (1990)
[10]
Fisher, Chapman, Tung, Morris, Alloimmunization to HLA antigens following transfusion with leukocytepoor and purified platelet suspensions, Vox Sang, 49, pp. 331-335, (1985)